BioHeart (BHRT)

Latest Trade: $0.60 0.00 (0.0%)

IPO News

Seattle-based biotech Omeros sets IPO terms 9/16/09
Biotech company BioHeart prices at midpoint of revised range 2/19/08
Biotech company BioHeart amends IPO terms 2/13/08
Biotech company BioHeart announces terms 9/6/07
Biotech company BioHeart files for IPO 2/13/07
Biotechnology firm Bioheart significantly cuts IPO deal size 10/12/02

Latest User Comments

Post Comment | Read More

Business

Business
A biotechnology company focused on using cells derived from a patient's body for treatment of heart damage.
Industry
Health-Biomed/Genetics
Employees
22
Founded
1999

Performance History

Invest in the IPO Plus Fund

First Day Return
5.0000

-4.8%
Aftermarket Return
5.0000

-88.0%
Return from IPO
5.2500

-88.6%

IPO Date
02/18/08
Offer Price
$5.25
Offer Shares
1.1 mm
We will not issue research on this IPO.
Lead Manager(s)
Merriman Curhan Ford
Dawson James

All Underwriters

BHRT Daily

Week

Month

Quarter

1 Year

Basic
Comps

Financial Data* ($ in millions)

Market Cap
$8.7
Revenues
$0
Net Income
($13)
*Revenues and Net Income are for last twelve months ending 09/30/06
View Prospectus and other SEC Filings

Corporate Data

Company Address
13794 NW 4th Street, Suite 212
Sunrise, FL
Phone Number
954-835-1500
Web Address
www.bioheartinc.com